Company relo anyone?
GlaxoSmithKline Plc (GSK) is grappling with a “war for talent” in China and India as the U.K. drugmaker struggles to retain sales representatives needed to expand in the world’s fastest-growing markets.
About 20 percent of Glaxo’s sales force in both countries quits each year in favor of better offers from rivals, said Abbas Hussain, 46, the London-based company’s president of emerging markets. That rate is about the same as the industry average in China and India, Hussain said in a March 28 interview at his office in Singapore.
“There’s a huge war for talent,” Hussain said. “It’s hard to do anything about. If you have a good person, they could find someone else willing to pay twice as much.”
http://www.bloomberg.com/news/2011-...lent-in-emerging-market-race-with-pfizer.html
GlaxoSmithKline Plc (GSK) is grappling with a “war for talent” in China and India as the U.K. drugmaker struggles to retain sales representatives needed to expand in the world’s fastest-growing markets.
About 20 percent of Glaxo’s sales force in both countries quits each year in favor of better offers from rivals, said Abbas Hussain, 46, the London-based company’s president of emerging markets. That rate is about the same as the industry average in China and India, Hussain said in a March 28 interview at his office in Singapore.
“There’s a huge war for talent,” Hussain said. “It’s hard to do anything about. If you have a good person, they could find someone else willing to pay twice as much.”
http://www.bloomberg.com/news/2011-...lent-in-emerging-market-race-with-pfizer.html